期刊文献+

抗人滋养层细胞表面抗原-2单抗的制备及免疫学特性分析 被引量:6

Preparation and immunologic characterization of a monoclonal antibody against human trophoblast cell-surface antigen 2
下载PDF
导出
摘要 目的:利用杂交瘤技术制备抗人滋养层细胞表面抗原-2(trophoblast cell-surface antigen 2,Trop2)单克隆抗体并鉴定其免疫学特性。方法:以胰腺癌细胞系BxPC3免疫BALB/c小鼠,取其脾细胞与SP2/0细胞融合后制备单抗。通过酶联免疫法、免疫荧光、免疫沉淀和质谱分析、流式细胞术、免疫组织化学等方法,鉴定单抗的免疫学特性。结果:通过细胞的融合与筛选,获得了持续分泌抗Trop2单抗的杂交瘤细胞株,该抗体可以识别细胞表面的Trop2膜蛋白,也可用于免疫组化识别人肿瘤组织中的Trop2蛋白,同时该抗体对乳腺癌细胞的生长具有一定的抑制作用。结论:该单抗具有作为Trop2阳性表达肿瘤靶向治疗的潜在应用价值。 Objective:To produce a monoclonal antibody(mAb) against human trophoblast cell-surface antigen 2(Trop2) with hybridoma technology and identify its immune specificity.Methods:The spleen cells from BALB/c mice immunized with pancreatic cancer cell line BxPC3 cells were fused with SP2/0 cells to produce a monoclonal antibody against human Trop2.Further,several immunological methods such as ELISA,IF,IP,MALDI-TOF MS,FACS and IHC were used to characterize the immune specificity of the mAb.Results:The results demonstrated that the specific mouse anti-human Trop2 mAb was successfully produced and can be secreted continuously and steadily.Moreover,this mAb can effectively recognize the transmembrane glycoprotein Trop2 over-expressed in human cancer cells and tissues.Conclusion:We successfully obtained mouse anti-human Trop2 mAb which may be potentially utilized for some tumor targeted therapy.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2011年第5期645-650,共6页 Journal of Nanjing Medical University(Natural Sciences)
基金 南京市医学科技发展重点项目(ZKX09015) 南京市科技发展项目(200901083)
关键词 人滋养层细胞表面抗原-2 单克隆抗体 免疫组化 Trop2 monoclonal antibody immunohistochemistry
  • 相关文献

参考文献1

二级参考文献14

  • 1Neoptolemos JP,Stocken DD,Friess H,et al.A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancerNew England Journal of Homeopathy,2004.
  • 2Klinkenbijl JH,Jeekel J,Sahmoud T,et al.Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Annals of Surgery . 1999
  • 3Takada T,Amano H,Yasuda H,et al.Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer . 2002
  • 4Neoptolemos J P,Dunn J A,Stocken D D,et al.Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet,The . 2001
  • 5Oettle H,Post S,Neuhaus P,Gellert K,Langrehr J,Ridwelski K, et al.Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. The Journal of The American Medical Association . 2007
  • 6European Study Group for Pancreatic Cancer.Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Annals of Surgery . 2001
  • 7Kalser MH,,Ellenberg SS.Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Archives of Surgery . 1985
  • 8Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group. Cancer . 1987
  • 9Yeo CJ,Abrams RA,Grochow LB,Sohn TA,Ord SE,Hruban RH, et al.Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single- institution experience. Annals of Surgery . 1997
  • 10Smeenk HG,van Eijck CH,Hop WC,Erdmann J,Tran KC,Debois M, et al.Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891. Annals of Surgery . 2007

共引文献4

同被引文献64

  • 1Wan-Yee Lau,Eric C.H.Lai.Development and controversies of adjuvant therapy for pancreatic cancer[J].Hepatobiliary & Pancreatic Diseases International,2008,7(2):121-125. 被引量:5
  • 2郑媛媛.肿瘤的单抗靶向疗法在国内的研究和应用进展[J].中国肿瘤生物治疗杂志,2006,13(1):70-72. 被引量:2
  • 3朱洁(综述),王绮如(审校).单克隆抗体药物在肿瘤靶向治疗中的应用与展望[J].中国医师杂志,2007,9(7):1006-1007. 被引量:4
  • 4朱伟(综述),罗兵(审校).EBV潜伏膜蛋白LMP2A的研究进展[J].国际病毒学杂志,2007,14(4):120-123. 被引量:4
  • 5丰有吉,沈铿.妇产科学[M].2版.北京:人民卫生出版社,2010:325.
  • 6Niedobitek G,Meru N,Delecluse HJ.Epstein-Barr virus infection and human malignancies [J].Int J Exp Pathol,2001,82(3):149-170.
  • 7Young LS,Dawson CW,Eliopoulos AG.The expression and function of Epstein-Barr virus encoded latent genes [J].Mol Pathol,2000,53(5):238-247.
  • 8Konishi K,Maruo S,Kato H,et al.Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-in-duced immortalization and virus activation[J].J Gen Vi-rol,2001,82(Pt 6):1451-1456.
  • 9Fruehling S,Lee SK,Herrold R,et al.Identification of la-tent membrane protein 2A(LMP2A)domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction [J].J Virol,1996,70(9):6216-6226.
  • 10Scholle F,Longnecker R,Raab-Traub N.Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent mem-brane protein 2:a role for C-terminal Src kinase [J].J Virol,1999,73(6):4767-4775.

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部